Clinical Trials Logo
  1. Home
  2. Graft Rejection
  3. NCT00450996

Analysis of a Beneficial Effect of Prolonges Topical Steroid Treatment After Low-risk Penetrating Keratoplasty

Graft Rejection Clinical Trial

Official title:
Phase 3: Analysis of a Beneficial Effect of Prolonges Topical Steroid Treatment After Low-risk Penetrating Keratoplasty

Clinical Trial Summary

PURPOSE: To assess the impact of duration of topical steroid treatment on the incidence of endothelial graft rejection following normal-risk penetrating keratoplasty (PK). DESIGN: Prospective, institutional, longitudinal, randomized interventional trial including 406 eyes (age: 52 >= 19 years; follow-up: 42 >= 18months). METHODS: Postoperative treatment started with prednisolone acetate 1% eye drops five times daily and was tapered over the first 6 months. Patients were then randomised into either short-term (stop topical steroid treatment) or long-term treatment (continue steroids once daily until 12 months).

Clinical Trial Description

PURPOSE: To assess the impact of duration of topical steroid treatment on the incidence of endothelial graft rejection following normal-risk penetrating keratoplasty (PK). DESIGN: Prospective, institutional, longitudinal, randomized interventional trial including 406 eyes (age: 52 >= 19 years; follow-up: 42 >= 18 months). METHODS: Postoperative treatment started with prednisolone acetate 1% eye drops five times daily and was tapered over the first 6 months. Patients were then randomised into either short-term (stop topical steroid treatment) or long-term treatment (continue steroids once daily until 12 months). <= ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00450996
Study type Interventional
Source University of Erlangen-Nürnberg Medical School
Contact
Status Completed
Phase N/A
Start date January 1999
Completion date March 2007
View Details
See also
  Status Clinical Trial Phase
Completed NCT00771875 - Randomized Trial for Mixed Acute Rejection Phase 2
Completed NCT00369382 - Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients Phase 4
Completed NCT01009619 - Azithromycin in Bronchiolitis Obliterans Syndrome Phase 4
Not yet recruiting NCT05072951 - Urine Biomarker for Kidney Transplant Rejection
Completed NCT01211509 - Montelukast in Bronchiolitis Obliterans Syndrome Phase 4
Recruiting NCT01066689 - Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation Phase 3
Completed NCT00251004 - Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients Phase 3
Completed NCT00254709 - Study Evaluating Two Different Sirolimus-based Immunosuppressive Regimens in Elderly Kidney Transplant Recipients Phase 4
Recruiting NCT04851145 - Mass Spectrometry-based Proteomics in Microvascular Inflammation Diagnosis in Kidney Transplantation. N/A
Completed NCT00001984 - Effectiveness of the Investigational Drug Campath-1H in Preventing Rejection of Transplanted Kidneys Phase 2
Completed NCT04488094 - Diagnostic Validity of [18F]FSPG PET for the Assessment of Acute Rejection After Heart or Liver Transplantation Phase 2
Not yet recruiting NCT03147157 - The Effect of Human Leukocyte Antigen Macthing on Guiding Tacrolimus Regimen After Liver Transplantation N/A
Completed NCT00761787 - Cardiac Allograft Rejection Gene Expression Observational (CARGO) II STUDY N/A
Completed NCT00000137 - Collaborative Corneal Transplantation Studies (CCTS) Phase 3
Completed NCT00266123 - Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant Recipients Phase 4
Completed NCT00035555 - Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney Phase 2
Completed NCT00001858 - Monitoring for Tolerance to Kidney or Combined Kidney-Pancreas Transplants
Completed NCT00895583 - Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients Phase 4
Completed NCT00089947 - A Study to Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant Rejection Phase 2
Enrolling by invitation NCT05285878 - Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation Phase 2